Your browser doesn't support javascript.
loading
Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.
Siedel, Jean H; Ring, Kari L; Hu, Wei; Dood, Robert L; Wang, Ying; Baggerly, Keith; Darcy, Kathleen M; Conrads, Thomas P; Gallagher, Shannon; Tshiaba, Placede; Neff, Chris; Timms, Kirsten M; Mangala, Selanere; Westin, Shannon N; Broaddus, Russell; Lopez-Berestein, Gabriel; Lu, Karen H; Coleman, Robert L; Maxwell, George L; Sood, Anil K.
Afiliación
  • Siedel JH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Ring KL; Department of Obstetrics and Gynecology, Emily Couric Clinical Cancer Center, Charlottesville, VA, United States of America.
  • Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Dood RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Wang Y; Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Baggerly K; Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Darcy KM; Gynecologic Cancer Center of Excellence, Department of Obstetrics & Gynecology, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, United States of America; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
  • Conrads TP; Gynecologic Cancer Center of Excellence, Department of Obstetrics & Gynecology, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, United States of America; Women's Health Integrated Research Center, Women's Service Line, Inova Healt
  • Gallagher S; Myriad Genetics, Inc., Salt Lake, UT, United States of America.
  • Tshiaba P; Myriad Genetics, Inc., Salt Lake, UT, United States of America.
  • Neff C; Myriad Genetics, Inc., Salt Lake, UT, United States of America.
  • Timms KM; Myriad Genetics, Inc., Salt Lake, UT, United States of America.
  • Mangala S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Broaddus R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, United States of America.
  • Lopez-Berestein G; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, United States of America.
  • Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Maxwell GL; Gynecologic Cancer Center of Excellence, Department of Obstetrics & Gynecology, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, United States of America; Women's Health Integrated Research Center, Women's Service Line, Inova Healt
  • Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Departmen
Gynecol Oncol ; 160(3): 777-785, 2021 03.
Article en En | MEDLINE | ID: mdl-33563487
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Recombinación Homóloga Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Recombinación Homóloga Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos